Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use

Acheampong, T., Lee Argov, E. J., Terry, M. B., Rodriguez, C. B., Agovino, M., Wei, Y., Athilat, S., & Tehranifar, P. (2022). Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use. Cancer Causes & Control, 33(3), 363–371. https://doi.org/10.1007/s10552-021-01530-1
Authors:
Teofilia Acheampong
Erica J. Lee Argov
Mary Beth Terry
Carmen B. Rodriguez
Mariangela Agovino
Ying Wei
Shweta Alithat
Parisa Tehranifar
Affiliated Authors:
Teofilia Acheampong
Erica J. Lee Argov
Mary Beth Terry
Carmen B. Rodriguez
Mariangela Agovino
Ying Wei
Shweta Alithat
Parisa Tehranifar
Columbia Affiliation:
Subjects:
Breast Neoplasms (MeSH)
Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
Metformin (MeSH)
Author Keywords:
breast cancer
breast density
mammography
aspirin
nsaid
elink
Publication Type:
Article
Unique ID:
10.1007/s10552-021-01530-1
PMID:
35022893
DOI:
10.1007/s10552-021-01530-1
Journal:
CCC: Cancer Causes and Control
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: